Navigation Links
Naturopathix, Inc. Brings Painless Molluscum Treatment to Asia on Governor's Trade Mission
Date:3/29/2013

Boise, ID (PRWEB) March 29, 2013

“We are delighted to have this opportunity to bring our painless molluscum treatment to people in Asia. ZymaDerm™ provides a simple and effective all natural dab on preparation which allows parents to avoid expensive, painful, and other usually ineffective treatments,” continued Dr. Burke.

"Idaho Governor "Butch" Otter has invited Naturopathix,Inc., along with several other select companies with innovative products, to travel to Asia this April on the Governor's Trade Mission", announced Briant Burke, MD, MS creator of ZymaDerm™ and medical director of Naturopathix,Inc.

ZymaDerm™ is the most widely used painless and inexpensive natural treatment to rapidly make the unsightly skin bumps simply vanish, especially in children. Since its introduction in 2003, it has enabled hundreds of thousands of people to quickly be rid of visible bumps caused by MCV.

The unsightly skin condition is highly contagious and is caused by the molluscum contagiosum virus. MCV is a pox virus but it is not related to chicken pox. The lesions often rapidly spread and occur most often on the face, neck, armpit, arms, and hands. However, it may occur anywhere on the body except the palms of the hands and soles of the feet.

Contagiosum in children is more common than in adults. They catch it when they come into contact with the virus, usually on the skin of another infected child or on a wet surface infected with the virus. It is a common infection throughout the world with an increased incidence in hot tropical and semi-tropical climates. In the US there are approximately 2 million new cases each year. However in Taiwan with its humid tropical climate there are an estimated 3 million cases, even though the population is much smaller. "We feel we can serve a real need by helping to bring relief to the peoples of Asia inflicted with this embarrassing condition", said Dr. Burke. Symptoms of this skin virus include raised, unsightly, warty lesions or bumps on the skin.

While the skin virus occurs primarily in young children, it is becoming epidemic amongst adults as well. ZymaDerm™ is as effective for adults as well as children, and may be used safely on all body areas including the face and private areas.

Many leading dermatology clinics and pediatricians are now replacing invasive and often painful treatments with this gentle, effective, natural treatment for their patients with molluscum contagiosum. Results of an independent follow up study of 356 physicians who used ZymaDerm™ samples found 86% reported ZymaDerm™ to be effective or highly effective in eliminating visible molluscum lesions in children.

A patented blend of powerful all natural plant-based compounds, ZymaDerm™ transforms the treatment of molluscum contagiosum from expensive and often painful procedures such as freezing, burning, or surgical removal of the lesions to simply dabbing on a pleasant aromatic blend twice a day, usually for less than a month, until the lesions completely vanish.

ABOUT ZYMADERM™

Naturopathix,Inc. was founded in 2002 with the mission to develop novel plant based therapeutic treatments for the relief of common medical conditions. The company is led by Dr. Briant Burke, a practicing physician and distinguished medical research scientist with over 20 years of clinical experience treating patients and publishing clinical trials. ZymaDerm™ for molluscum contagiosum is FDA approved as a homeopathic drug. Its ingredients are officially included in the Homeopathic Pharmacopeia of the United States as useful agents. The potency and level of purity of the ingredients in ZymaDerm™ meet the most stringent standards of excellence.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10564773.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Finding brings scientists 1 step closer to Parkinsons drug
2. Breakthrough Brings Transparency to Male/Female Relationships
3. Conference brings global focus to social inequality
4. Telephone therapy technique brings more Iraq and Afghanistan veterans into mental health treatment
5. Winter Brings Rise in Heart-Related Deaths, Study Finds
6. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
7. Acoustical Treatment Brings Tidings of Comfort and Joy on ASI Blogs
8. Catalyst Exhibits Brings Big Presence to 2012 RSNA Show
9. Maui Wowi Brings Hawaii to the Atlantic
10. Fidelity Investments Brings the Happiness of the Holidays to Five Educational First Steps Assisted Centers
11. LesserEvil Healthy Brands Brings Chia Crisps to Wegman's
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology: